SWP
ABBV icon

Semus Wealth Partners’s AbbVie ABBV Stock Holding History

Semus Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$544K Buy
2,503
+3
+0.1% +$665 0.3% 59
2025
Q4 		$571K Buy
2,500
+11
+0.4% +$2.51K 0.31% 57
2025
Q3 		$576K Buy
2,489
+39
+2% +$7.94K 0.33% 52
2025
Q2 		$455K Buy
2,450
+23
+0.9% +$4.28K 0.29% 63
2025
Q1 		$508K Buy
2,427
+35
+1% +$6.8K 0.35% 51
2024
Q4 		$425K Sell
2,392
-41
-2% -$7.54K 0.28% 63
2024
Q3 		$480K Buy
2,433
+27
+1% +$5.04K 0.34% 57
2024
Q2 		$413K Buy
2,406
+231
+11% +$38.3K 0.32% 60
2024
Q1 		$396K Sell
2,175
-1
-0% -$172 0.33% 72
2023
Q4 		$337K Buy
2,176
+23
+1% +$3.35K 0.28% 79
2023
Q3 		$321K Buy
2,153
+17
+0.8% +$2.5K 0.3% 77
2023
Q2 		$288K Sell
2,136
-38
-2% -$5.57K 0.26% 86
2023
Q1 		$346K Sell
2,174
-212
-9% -$32.4K 0.37% 65
2022
Q4 		$386K Buy
+2,386
New +$366K 0.47% 59

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Semus Wealth Partners's ABBV Position: Q1 2026 in Review

Semus Wealth Partners increased its AbbVie (ABBV) stake by 0.12% in Q1 2026, buying an estimated $665 and bringing the position to 2,503 shares worth $544K. The position accounts for 0.3% of the portfolio, ranked #59.

Semus Wealth Partners first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. The position peaked at $576K in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Semus Wealth Partners held 2,503 shares of AbbVie worth $544K as of Q1 2026.
  • Semus Wealth Partners bought 3 AbbVie shares in Q1 2026, an estimated $665.
  • AbbVie made up 0.3% of Semus Wealth Partners's portfolio in Q1 2026, its #59 holding.
  • Semus Wealth Partners first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
  • Semus Wealth Partners's AbbVie position peaked at $576K in Q3 2025.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Semus Wealth Partners's 13F filing for Q1 2026, filed 24 Apr 2026.